Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the Lungs - Concepedia

Concepedia

Publication | Closed Access

Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the Lungs

129

Citations

16

References

2007

Year

Gregory A. Otterson, Miguel A. Villalona‐Calero, Sunil Sharma, Mark G. Kris, A. R. Imondi, Mirjam C. Gerber, Dorothy A. White, Mark J. Ratain, Joan H. Schiller, Alan Sandler,

Clinical Cancer Research

Abstract

Inhaled doxorubicin is safe up to a dose of 7.5 mg/m(2) every 3 weeks in patients with cancer who had normal to moderately impaired pulmonary function.

References

	Year	Citations

Page 1